Table 5. Univariate and multivariate analysis of factors associated with CT or NG infection in women in Kigali, Rwanda (N = 579).
CT infection | NG infection | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cPOR | 95% CI | p-value | aPOR | 95% CI | p-value | cPOR | 95% CI | p-value | aPOR | 95% CI | p-value | |||||
Demographics | ||||||||||||||||
Age (per year increase) | 0.91 | 0.88 | 0.95 | <0.0001 | 0.90 | 0.86 | 0.94 | <0.0001 | 0.95 | 0.92 | 0.97 | < .001 | 0.93 | 0.89 | 0.97 | <0.001 |
Referrer | ||||||||||||||||
Radio Advert | ref | ref | ||||||||||||||
Friends/Walk-in/Pharmacy/Contact Partner/Internet | 1.74 | 1.11 | 2.72 | 0.015 | 1.31 | 0.91 | 1.90 | 0.150 | ||||||||
Living and Marital Status | ||||||||||||||||
Married and Cohabiting | ref | ref | ||||||||||||||
Other | 1.78 | 1.13 | 2.80 | 0.012 | 1.46 | 1.00 | 2.13 | 0.048 | ||||||||
Education Level | ||||||||||||||||
None/Primary | ref | 2.09 | 1.44 | 3.04 | 0.000 | 2.13 | 1.30 | 3.48 | 0.003 | |||||||
Secondary/Higher | 1.30 | 0.83 | 2.01 | 0.248 | ref | ref | ||||||||||
Employment Status | ||||||||||||||||
Full-time employment | ref | ref | ref | |||||||||||||
Part-time/Student/Jobless | 1.23 | 0.77 | 1.96 | 0.383 | 1.76 | 1.16 | 2.66 | 0.008 | 1.95 | 1.12 | 3.39 | 0.019 | ||||
Sexual behaviors | ||||||||||||||||
Number of partners in last 30 days | ||||||||||||||||
None or one partner | ref | ref | ||||||||||||||
More than one partner | 1.56 | 0.89 | 2.75 | 0.119 | 3.53 | 2.19 | 5.69 | <0.0001 | ||||||||
Condom use during vaginal sex in the last 3 months | ||||||||||||||||
No partners or always used condoms | 1.17 | 0.46 | 2.97 | 0.741 | 0.48 | 0.15 | 1.5 | 0.207 | 0.74 | 0.22 | 2.41 | 0.611 | ||||
Sometimes | 1.49 | 0.92 | 2.42 | 0.107 | 2.75 | 1.81 | 4.18 | <0.0001 | 1.79 | 1.07 | 2.98 | 0.025 | ||||
Never | ref | ref | ref | |||||||||||||
Number of days since sexual contact you suspect STI was acquired from | ||||||||||||||||
0–8 | 1.20 | 0.53 | 2.69 | 0.666 | 1.66 | 0.87 | 3.16 | 0.126 | ||||||||
9–16 | 1.96 | 1.1 | 3.49 | 0.022 | 2.29 | 1.36 | 3.87 | 0.002 | ||||||||
> = 17 | ref | ref | ||||||||||||||
Number of children under 18 (per child increase) | 0.82 | 0.69 | 0.99 | 0.037 | 0.96 | 0.84 | 1.10 | 0.594 | ||||||||
Number of additional children desired (per child increase) | 1.22 | 1.02 | 1.45 | 0.027 | 0.92 | 0.79 | 1.07 | 0.274 | ||||||||
Family planning method and pregnancy composite | ||||||||||||||||
Pregnant | 0.96 | 0.43 | 2.14 | 0.915 | 1.00 | 0.49 | 2.03 | 0.999 | 1.30 | 0.57 | 2.99 | 0.532 | ||||
Hormonal method (implant, injectable, pills) | 0.95 | 0.56 | 1.59 | 0.837 | 2.01 | 1.32 | 3.05 | 0.001 | 1.73 | 1.02 | 2.94 | 0.040 | ||||
Non-Hormonal (IUD/Condom/Tubal Ligation/Natural Method) or No Method | ref | ref | ref | |||||||||||||
Self-reported symptoms | ||||||||||||||||
Vaginal discharge | ||||||||||||||||
Yes | ref | ref | ||||||||||||||
No | 1.26 | 0.73 | 2.18 | 0.408 | 1.10 | 0.68 | 1.78 | 0.692 | ||||||||
Genital itching | ||||||||||||||||
Yes | ref | ref | ref | |||||||||||||
No | 1.08 | 0.69 | 1.68 | 0.738 | 2.62 | 1.79 | 3.84 | <0.0001 | 2.54 | 1.55 | 4.17 | 0.0002 | ||||
Dysuria | ||||||||||||||||
Yes | ref | 1.21 | 0.84 | 1.75 | 0.303 | |||||||||||
No | 1.06 | 0.68 | 1.64 | 0.796 | ref | |||||||||||
Genital ulcer | ||||||||||||||||
Yes | ref | ref | ref | |||||||||||||
No | 1.30 | 0.62 | 2.73 | 0.489 | 2.33 | 1.12 | 4.84 | 0.024 | 2.52 | 1.09 | 5.80 | 0.030 | ||||
Number of days with symptoms | ||||||||||||||||
1–10 | 1.72 | 1.06 | 2.78 | 0.027 | 1.76 | 1.07 | 2.88 | 0.026 | 1.76 | 1.16 | 2.68 | 0.008 | 1.78 | 1.05 | 3.00 | 0.032 |
11 or more | ref | ref | ref | ref | ||||||||||||
Laboratory and physical exam | ||||||||||||||||
HIV Status | ||||||||||||||||
Positive | ref | 2.73 | 1.66 | 4.47 | <0.0001 | 2.05 | 1.10 | 3.83 | 0.024 | |||||||
Negative | 1.83 | 0.85 | 3.96 | 0.124 | ref | ref | ||||||||||
RPR Result | ||||||||||||||||
Positive | 1.37 | 0.66 | 2.88 | 0.401 | 2.58 | 1.41 | 4.7 | 0.002 | ||||||||
Negative | ref | ref | ||||||||||||||
Trichomonas | ||||||||||||||||
Positive | 1.85 | 1.03 | 3.32 | 0.041 | ref | |||||||||||
Negative | ref | 1.06 | 0.60 | 1.88 | 0.838 | |||||||||||
Candida | ||||||||||||||||
Positive | ref | ref | ref | |||||||||||||
Negative | 1.98 | 1.04 | 3.77 | 0.038 | 3.56 | 1.89 | 6.69 | <0.0001 | 2.20 | 1.11 | 4.36 | 0.024 | ||||
Bacterial vaginosis | ||||||||||||||||
Positive | 1.63 | 0.98 | 2.72 | 0.063 | 2.63 | 1.67 | 4.15 | <0.0001 | 1.89 | 1.07 | 3.34 | 0.028 | ||||
Negative | ref | ref | ref | |||||||||||||
Vaginal Inflammation OR Discharge | ||||||||||||||||
Yes | ref | ref | ||||||||||||||
No | 1.47 | 0.79 | 2.75 | 0.2201 | 1.67 | 0.97 | 2.86 | 0.063 | ||||||||
Endocervical Inflammation or Discharge | ||||||||||||||||
Yes | 1.83 | 1.15 | 2.91 | 0.010 | 2.17 | 1.46 | 3.23 | 0.000 | 1.80 | 1.11 | 2.93 | 0.018 | ||||
No | ref | ref | ref | |||||||||||||
Genital Ulcer | ||||||||||||||||
Yes | 1.19 | 0.56 | 2.56 | 0.649 | ref | |||||||||||
No | ref | 1.06 | 0.53 | 2.10 | 0.875 |
IUD: intrauterine device; aPOR: Adjusted prevalence odds ratio; cPOR: Crude prevalence odds ratio; RPR: Rapid plasma reagin; CI: Confidence interval; STI: Sexually transmitted disease; NG: Neisseria gonorrhoeae, CT: Chlamydia trachomatis